Bpifrance and Balestier participate in €27 million financing round of LimFlow
Client(s) Bpifrance and Balestier
Jones Day represented Bpifrance and Balestier in connection with a €27 million (US$33.5 million) Series C round of financing of LimFlow SA, a developer of innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia.